Search research articles

Search research articles

Related Experiment Videos

Subclinical thyroid disease.

George R Wilson¹, R Whit Curry

¹Department of Community Health and Family Medicine, University of Florida Health Science Center, Jacksonville, Florida 32209, USA. george.wilson@jax.ufl.edu

American Family Physician

|November 9, 2005

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Onset of Fear and the Onset of Pain in Cardiac Disturbance.

Transactions. Medico-Chirurgical Society of Edinburgh·2018

Same author

The pervalence of caecal threadworms (Trichostrongylus tenuis) in red grouse (Lagopus lagopus scoticus).

Oecologia·2017

Same author

Ideas and innovations: inclusion of pharmacists in chronic pain management services in a primary care practice.

Journal of opioid management·2012

Same author

Undiagnosed cognitive impairment in nursing home residents.

Journal of the American Geriatrics Society·2011

Same author

Ethyl glucuronide, ethyl sulfate, and ethanol in urine after intensive exposure to high ethanol content mouthwash.

Journal of analytical toxicology·2011

Same author

Blocks of the sympathetic axis for visceral pain, 2nd edition #97.

Journal of palliative medicine·2011

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Subclinical thyroid dysfunction, including hypothyroidism and hyperthyroidism, affects a significant portion of the population. Current evidence suggests limited benefits from treating these conditions, with controversial management strategies.

Area of Science:

Endocrinology
Internal Medicine
Thyroidology

Background:

Subclinical thyroid dysfunction is characterized by abnormal thyroid-stimulating hormone (TSH) levels with normal free thyroxine and triiodothyronine.
Prevalence varies, with subclinical hypothyroidism affecting 4-8.5% (up to 20% in women >60) and subclinical hyperthyroidism affecting ~2% of the population.
Routine screening for asymptomatic individuals is generally not recommended, though high-risk groups may benefit.

Purpose of the Study:

To review the current understanding and controversial management of subclinical thyroid dysfunction.
To evaluate the associations and evidence for treatment benefits in subclinical hypothyroidism and hyperthyroidism.

Main Methods:

Literature review and synthesis of existing evidence on subclinical thyroid dysfunction.

Related Experiment Videos

Analysis of associations between abnormal TSH levels and clinical outcomes.

Assessment of evidence supporting the benefits of treatment for subclinical thyroid dysfunction.

Main Results:

Subclinical hypothyroidism is linked to progression to overt disease and, with TSH >10 microU/mL, to elevated LDL cholesterol.
Subclinical hyperthyroidism (TSH <0.1 microU/mL) is associated with overt hyperthyroidism, atrial fibrillation, reduced bone density, and cardiac dysfunction.
Evidence for the beneficial effects of treating subclinical hypothyroidism is insufficient, and early treatment for subclinical hyperthyroidism shows little impact on the clinical course.

Conclusions:

The management of subclinical thyroid dysfunction remains controversial due to limited evidence of treatment benefits.
While certain TSH levels are associated with adverse outcomes, early intervention does not consistently alter the clinical trajectory.
Further research is needed to clarify optimal management strategies for subclinical thyroid dysfunction in various patient populations.